Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer
Author:
Affiliation:
1. Vascular Biology ProgramChildren's Hospital BostonBostonMassachusettsUSA
2. Department of SurgeryChildren's Hospital BostonBostonMassachusettsUSA
3. Department of SurgeryHarvard Medical SchoolBostonMassachusettsUSA
Funder
National Institutes of Health
Breast Cancer Research Foundation
Publisher
Wiley
Subject
Genetics,Molecular Biology,Biochemistry,Biotechnology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.12-211730
Reference29 articles.
1. Lipocalin 2: A multifaceted modulator of human cancer
2. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns;Gruvberger S.;Cancer Res.,2001
3. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer
4. Lipocalin 2 promotes breast cancer progression
5. NGAL decreases E-cadherin-mediated cell–cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells
Cited by 105 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity;Bioactive Materials;2024-12
2. Mammary adipocytes promote breast tumor cell invasion and angiogenesis in the context of menopause and obesity;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10
3. Lipocalin-2 promotes breast cancer brain metastasis by enhancing tumor invasion and modulating brain microenvironment;Frontiers in Oncology;2024-08-12
4. Prognostic heterogeneity of Ki67 in non‐small cell lung cancer: A comprehensive reappraisal on immunohistochemistry and transcriptional data;Journal of Cellular and Molecular Medicine;2024-07
5. Lipocalin‐2 as a prognostic biomarker and its association with systemic inflammation in small cell lung cancer;Thoracic Cancer;2024-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3